title: An analysis of 170 glioma patients and systematic review to investigate the association between IDH-1 mutations and preoperative glioma-related epilepsy.
abstract: Seizure is a common presenting symptom of glioma, and many biomarkers have been suggested to be associated with preoperative seizure; however, the relationships between IDH (isocitrate dehydrogenase) mutations and glioma-related epilepsy only recently been studied. The authors aimed to examine the correlations between IDH mutations in glioma patients with preoperative seizures and tumor location. A series of 170 glioma samples were analyzed for IDH1 R132H mutations (amino acid change from arginine to histidine at codon 132) with immunohistochemistry (IHC) staining and for IDH mutations with direct DNA sequencing when the IHC results were negative. If either the IHC or direct DNA sequencing result was positive, the IDH status was defined as mutated. The results of the IDH mutation examinations were used to analyze the relationship between mutations and glioma-related epilepsy. The study population consisted of 64 (37.6%) World Health Organization (WHO) grade II gliomas, 58 (34.1%) grade III, and 48 (28.3%) grade IV gliomas. A total of 84 samples with IDH1 mutations were observed in our study, and 54 of these presented with seizures as the initial symptoms, whereas 28 of the patients with wild-type IDH status presented with seizures (p=0.043 for the WHO grade II gliomas, p=0.002 for the grade III gliomas and p=0.942 for the grade IV gliomas, chi-squared tests). Among the WHO grade II and III gliomas, IDH1 mutations were significantly associated with preoperative seizures, but no significant relationship between IDH mutations and preoperative seizures was found with glioblastoma multiforme.
authors.affiliation: Department of Neurosurgery, Waiguoxuexiang No. 37, West China Hospital, Si Chuan University, Chengdu 610041, Sichuan Province, China.
authors.forename: Yuan
authors.initials: Y
authors.lastname: Yang
authors.affiliation: Department of Neurosurgery, Waiguoxuexiang No. 37, West China Hospital, Si Chuan University, Chengdu 610041, Sichuan Province, China. Electronic address: qingmao2000@163.com.
authors.forename: Qing
authors.initials: Q
authors.lastname: Mao
authors.affiliation: Department of Neurosurgery, Waiguoxuexiang No. 37, West China Hospital, Si Chuan University, Chengdu 610041, Sichuan Province, China.
authors.forename: Xiang
authors.initials: X
authors.lastname: Wang
authors.affiliation: Department of Neurosurgery, Waiguoxuexiang No. 37, West China Hospital, Si Chuan University, Chengdu 610041, Sichuan Province, China.
authors.forename: Yanhui
authors.initials: Y
authors.lastname: Liu
authors.affiliation: West China Medical School of Si Chuan University, Chengdu 610041, Sichuan Province, China.
authors.forename: Yunhe
authors.initials: Y
authors.lastname: Mao
authors.affiliation: Department of Neuropathology, West China Hospital, Si Chuan University, Chengdu 610041, Sichuan Province, China.
authors.forename: Qiao
authors.initials: Q
authors.lastname: Zhou
authors.affiliation: Department of Neurosurgery, Waiguoxuexiang No. 37, West China Hospital, Si Chuan University, Chengdu 610041, Sichuan Province, China.
authors.forename: Jiewen
authors.initials: J
authors.lastname: Luo
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D001932:Brain Neoplasms / Q000150:complications / Q000000981:diagnostic imaging / Q000235:genetics*; D004827:Epilepsy / Q000209:etiology / Q000235:genetics*; D005260:Female; D005910:Glioma / Q000150:complications / Q000000981:diagnostic imaging / Q000235:genetics*; D006801:Humans; D007521:Isocitrate Dehydrogenase / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D009154:Mutation; D055815:Young Adult
chemical_list: D007521:Isocitrate Dehydrogenase; C543588:IDH1 protein, human
keywords: Biomarker; Glioma; IDH mutation; Ki-67 proliferation marker; Meta-analysis; Seizure